Cipla's MK Hamied Steps Down, Kamil Hamied to Join Board

MK Hamied, Vice Chairman of drug major Cipla, has resigned due to age and health reasons. His resignation is effective from October 29. The company's board has approved the appointment of Kamil Hamied as Non-Executive Director starting November 1, 2024.

In a significant organizational shift, drug major Cipla announced that MK Hamied has resigned as Vice Chairman, citing age and health concerns. His resignation will take effect on October 29.

Hamied communicated this decision in a heartfelt letter to the board of directors, expressing his heavy heart at stepping down from his role as Vice Chairman and Non-Executive Director.

To ensure continuity and uphold the family's legacy, the board has approved the appointment of Kamil Hamied as Non-Executive Director, effective November 1, 2024.

(With inputs from agencies.)